Navigation Links
Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
Date:6/17/2013

ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication campaign "Millions of Reasons, One Purpose, Repositioning Prime Therapeutics." The award was presented at the Public Relations Society of America (PRSA) 2013 Silver Anvil Awards Ceremony held June 13 at the AXA Equitable Center in New York.

The Silver Anvil, which has been presented annually since 1946, is the oldest and one of the most prestigious awards competitions for outstanding achievement in public relations, based on its rigorous judging criteria and emphasis on measurement and evaluation.

"This Silver Anvil award recognizes work we undertook to simplify and redefine our purpose statement to clearly reflect the important work we do to help people get the medicine they need to feel better and live well," said Michael Showalter, chief marketing officer at Prime. "Our employees have embraced this new purpose statement because it focuses on the people we truly serve."

PRSA, which is based in New York, is the largest professional organization serving the U.S. public relations community. With a mission to "advance the profession and the professional," PRSA provides news and information, thought leadership, continuing education and networking opportunities. It also sets standards of professional excellence and advocates for the business value of public relations.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation. 

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tras el exitoso lanzamiento en Estados Unidos, el nuevo Simbionix U/S Mentor se introducirá por primera vez en Europa
2. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
3. Prime Therapeutics specialty pharmacy receives URAC accreditation
4. Zydus Demonstra Pioneirismo com o Inovador LIPAGLYN, Primeiro NCE da Índia a Entrar no Mercado
5. Prime Therapeutics appoints Scott Fries as senior vice president of government programs
6. Primex Wireless Adds Differential Pressure Monitoring to IAQ lineup with Release of SNS Application Management Platform (AMP 4.0)
7. Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
8. Sanomedics Signs Definitive Agreement to Acquire Prime Time Medical
9. PrimerLife.com celebra el aniversario del descubrimiento del ADN con una nueva red social
10. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
11. Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... of their latest industry white paper, entitled Barriers to Adoption of the ERA ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), an ... orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with ... magnesium, a critical property for bone health and development. , “We’re excited to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):